Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Technology Stocks News 11

Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day at $2.60. Traded volume was 16.17million shares in the last session and the average volume of the stock remained 7.80million shares. The beta of the stock remained 3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) insider ownership is 2.80%.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Bruce Kovner bought 1,250,000 shares of the company’s stock in a transaction that occurred on Friday, April 11th. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) closed to $4.09 Tuesday on volume of 2.60million shares. The intra-day range of the stock was $3.93 to $4.24. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has a market capitalization of $349.43million.

Repligen Corporation (NASDAQ:RGEN) had its buy rating reiterated by analysts at Jefferies Group. Jefferies Group currently has a $17.00 price target on the stock. Repligen Corporation (NASDAQ:RGEN)’s stock on Apr 15, 2014 reported a increase of 5.12% to the closing price of $14.37. Its fifty two weeks range is $7.37 -$17.26. The total market capitalization recorded $460.41million. The overall volume in the last trading session was 858,577.00million shares. In its share capital, RGEN has 32.04million outstanding shares.

On Tuesday, shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO) dropped -8.88% to close the day at $40.00. Company return on investment (ROI) is -30.00% and its monthly performance is recorded as -4.24%. Agios Pharmaceuticals Inc (NASDAQ:AGIO) quarterly revenue growth is 12.42%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone